Morgan Stanley’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Buy |
178,243
+177,943
| +59,314% | +$189K | ﹤0.01% | 5871 |
|
|
2025
Q1 | $408 | Hold |
300
| – | – | ﹤0.01% | 7401 |
|
|
2024
Q4 | $414 | Sell |
300
-3
| -1% | -$4 | ﹤0.01% | 7363 |
|
|
2024
Q3 | $324 | Sell |
303
-17,158
| -98% | -$18.3K | ﹤0.01% | 7345 |
|
|
2024
Q2 | $37.5K | Buy |
17,461
+13,297
| +319% | +$28.6K | ﹤0.01% | 6260 |
|
|
2024
Q1 | $13.5K | Sell |
4,164
-2,498
| -37% | -$8.12K | ﹤0.01% | 6590 |
|
|
2023
Q4 | $137K | Buy |
6,662
+3,877
| +139% | +$79.4K | ﹤0.01% | 6068 |
|
|
2023
Q3 | $44.8K | Sell |
2,785
-39,457
| -93% | -$634K | ﹤0.01% | 6211 |
|
|
2023
Q2 | $359K | Sell |
42,242
-3,290
| -7% | -$28K | ﹤0.01% | 5382 |
|
|
2023
Q1 | $449K | Buy |
45,532
+4,227
| +10% | +$41.7K | ﹤0.01% | 5320 |
|
|
2022
Q4 | $394K | Buy |
41,305
+1,072
| +3% | +$10.2K | ﹤0.01% | 5358 |
|
|
2022
Q3 | $699K | Sell |
40,233
-98
| -0.2% | -$1.7K | ﹤0.01% | 5095 |
|
|
2022
Q2 | $313K | Buy |
40,331
+39,446
| +4,457% | +$306K | ﹤0.01% | 5660 |
|
|
2022
Q1 | $14K | Buy |
+885
| New | +$14K | ﹤0.01% | 7278 |
|